Literature DB >> 29339779

Novel recessive mutations in MSTO1 cause cerebellar atrophy with pigmentary retinopathy.

Kazuhiro Iwama1,2, Toru Takaori3, Ai Fukushima4, Jun Tohyama5, Akihiko Ishiyama3, Chihiro Ohba1, Satomi Mitsuhashi1, Satoko Miyatake1,6, Atsushi Takata1, Noriko Miyake1, Shuichi Ito2,6, Hirotomo Saitsu7, Takeshi Mizuguchi1, Naomichi Matsumoto8.   

Abstract

Misato 1, mitochondrial distribution and morphology regulator (encoded by the MSTO1 gene), is involved in mitochondrial distribution and morphology. Recently, MSTO1 mutations have been shown to cause clinical manifestations suggestive of mitochondrial dysfunction, such as muscle weakness, short stature, motor developmental delay, and cerebellar atrophy. Both autosomal dominant and recessive modes of inheritance have been suggested. We performed whole-exome sequencing in two unrelated patients showing cerebellar atrophy, intellectual disability, and pigmentary retinopathy. Three novel mutations were identified: c.836 G > A (p.Arg279His), c.1099-1 G > A (p.Val367Trpfs*2), and c.79 C > T (p.Gln27*). Both patients had compound heterozygous mutations with a combination of protein-truncation mutation and missense mutation, the latter shared by them both. This survey of two patients with recessive and novel MSTO1 mutations provides additional clinical and genetic information on the pathogenicity of MSTO1 in humans.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29339779     DOI: 10.1038/s10038-017-0405-8

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  14 in total

1.  Bioenergetic defect associated with mKATP channel opening in a mouse model carrying a mitofusin 2 mutation.

Authors:  Virginie Guillet; Naïg Gueguen; Romain Cartoni; Arnaud Chevrollier; Valérie Desquiret; Claire Angebault; Patrizia Amati-Bonneau; Vincent Procaccio; Dominique Bonneau; Jean-Claude Martinou; Pascal Reynier
Journal:  FASEB J       Date:  2011-02-01       Impact factor: 5.191

2.  An essential cell division gene of Drosophila, absent from Saccharomyces, encodes an unusual protein with tubulin-like and myosin-like peptide motifs.

Authors:  G L Miklos; M Yamamoto; R G Burns; R Maleszka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

3.  Disturbed mitochondrial and peroxisomal dynamics due to loss of MFF causes Leigh-like encephalopathy, optic atrophy and peripheral neuropathy.

Authors:  Johannes Koch; René G Feichtinger; Peter Freisinger; Mechthild Pies; Falk Schrödl; Arcangela Iuso; Wolfgang Sperl; Johannes A Mayr; Holger Prokisch; Tobias B Haack
Journal:  J Med Genet       Date:  2016-01-18       Impact factor: 6.318

4.  OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28.

Authors:  C Alexander; M Votruba; U E Pesch; D L Thiselton; S Mayer; A Moore; M Rodriguez; U Kellner; B Leo-Kottler; G Auburger; S S Bhattacharya; B Wissinger
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

5.  Milder progressive cerebellar atrophy caused by biallelic SEPSECS mutations.

Authors:  Kazuhiro Iwama; Masayuki Sasaki; Shinichi Hirabayashi; Chihiro Ohba; Emi Iwabuchi; Satoko Miyatake; Mitsuko Nakashima; Noriko Miyake; Shuichi Ito; Hirotomo Saitsu; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2016-02-18       Impact factor: 3.172

6.  A defect in myoblast fusion underlies Carey-Fineman-Ziter syndrome.

Authors:  Silvio Alessandro Di Gioia; Samantha Connors; Norisada Matsunami; Jessica Cannavino; Matthew F Rose; Nicole M Gilette; Pietro Artoni; Nara Lygia de Macena Sobreira; Wai-Man Chan; Bryn D Webb; Caroline D Robson; Long Cheng; Carol Van Ryzin; Andres Ramirez-Martinez; Payam Mohassel; Mark Leppert; Mary Beth Scholand; Christopher Grunseich; Carlos R Ferreira; Tyler Hartman; Ian M Hayes; Tim Morgan; David M Markie; Michela Fagiolini; Amy Swift; Peter S Chines; Carlos E Speck-Martins; Francis S Collins; Ethylin Wang Jabs; Carsten G Bönnemann; Eric N Olson; John C Carey; Stephen P Robertson; Irini Manoli; Elizabeth C Engle
Journal:  Nat Commun       Date:  2017-07-06       Impact factor: 14.919

7.  Recessive mutations in MSTO1 cause mitochondrial dynamics impairment, leading to myopathy and ataxia.

Authors:  Alessia Nasca; Chiara Scotton; Irina Zaharieva; Marcella Neri; Rita Selvatici; Olafur Thor Magnusson; Aniko Gal; David Weaver; Rachele Rossi; Annarita Armaroli; Marika Pane; Rahul Phadke; Anna Sarkozy; Francesco Muntoni; Imelda Hughes; Antonella Cecconi; György Hajnóczky; Alice Donati; Eugenio Mercuri; Massimo Zeviani; Alessandra Ferlini; Daniele Ghezzi
Journal:  Hum Mutat       Date:  2017-06-06       Impact factor: 4.878

Review 8.  Mechanism and regulation of the nonsense-mediated decay pathway.

Authors:  Nele Hug; Dasa Longman; Javier F Cáceres
Journal:  Nucleic Acids Res       Date:  2016-01-14       Impact factor: 16.971

Review 9.  The genetics and pathology of mitochondrial disease.

Authors:  Charlotte L Alston; Mariana C Rocha; Nichola Z Lax; Doug M Turnbull; Robert W Taylor
Journal:  J Pathol       Date:  2016-11-02       Impact factor: 7.996

Review 10.  Myopathology of Adult and Paediatric Mitochondrial Diseases.

Authors:  Rahul Phadke
Journal:  J Clin Med       Date:  2017-07-04       Impact factor: 4.241

View more
  4 in total

1.  MSTO1 mutations cause mtDNA depletion, manifesting as muscular dystrophy with cerebellar involvement.

Authors:  S Donkervoort; R Sabouny; P Yun; L Gauquelin; K R Chao; Y Hu; I Al Khatib; A Töpf; P Mohassel; B B Cummings; R Kaur; D Saade; S A Moore; L B Waddell; M A Farrar; J K Goodrich; P Uapinyoying; S H S Chan; A Javed; M E Leach; P Karachunski; J Dalton; L Medne; A Harper; C Thompson; I Thiffault; S Specht; R E Lamont; C Saunders; H Racher; F P Bernier; D Mowat; N Witting; J Vissing; R Hanson; K A Coffman; M Hainlen; J S Parboosingh; A Carnevale; G Yoon; R E Schnur; K M Boycott; J K Mah; V Straub; A Reghan Foley; A M Innes; C G Bönnemann; T E Shutt
Journal:  Acta Neuropathol       Date:  2019-08-29       Impact factor: 17.088

2.  Novel biallelic variants in MSTO1 associated with mitochondrial myopathy.

Authors:  Laura Schultz-Rogers; Alejandro Ferrer; Nikita R Dsouza; Michael T Zimmermann; Benn E Smith; Eric W Klee; Radhika Dhamija
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-12-13

Review 3.  Mitochondrial Dynamics: Molecular Mechanisms, Related Primary Mitochondrial Disorders and Therapeutic Approaches.

Authors:  Michela Di Nottia; Daniela Verrigni; Alessandra Torraco; Teresa Rizza; Enrico Bertini; Rosalba Carrozzo
Journal:  Genes (Basel)       Date:  2021-02-10       Impact factor: 4.096

4.  Case Report: Evidences of myasthenia and cerebellar atrophy in a chinese patient with novel compound heterozygous MSTO1 variants.

Authors:  Liqun Liu; Ruiting Su; Peng Huang; Xingfang Li; Jie Xiong; Yangyang Xiao; Dingan Mao; Lingjuan Liu
Journal:  Front Genet       Date:  2022-08-11       Impact factor: 4.772

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.